Introduction
More than 50% of the world's population harbor Helicobacter pylori in the upper gastrointestinal tract. However, more than 80% of individuals infected with this bacterium are asymptomatic; only a fraction of infected individuals develop clinical disease [1, 2] . The clinical response to infection is likely determined by the virulence of the infecting strain and the host genetic predisposition, as well as environmental factors. Virulent H. pylori strains having cytotoxin-associated gene pathogenicity islands (cag PAI) have been associated with a more aggressive clinical course due to the increased infl ammatory response of the gastric mucosa [3] [4] [5] [6] . H. pylori cagA, a type of cag PAI, is associated with severe gastritis and gastric carcinoma. Patients infected with H. pylori who have cagA antibodies are more likely to develop gastric cancer compared to uninfected patients or H. pylori-infected patients without cagA antibodies [7] [8] [9] . In a recent study, H. pylori cagL was identifi ed as a specialized adhesin protein that targets the pilus surface, where it binds to and activates the integrin α5ß1 receptor on the gastric epithelial surface, which facilitates the injection of cagA into host cells and activates host tyrosine kinases [10] . However, there is limited information currently available on the role of cag PAI in vivo, especially in premalignant gastric lesions, and the mechanism concerning how it contributes to gastric carcinogenesis is still obscure.
Matrix metalloproteinases (MMPs) are a family of diverse zinc-dependent proteolytic enzymes that are important in the maintenance and remodeling of the cell-cell matrix and the extracellular matrix. MMP-7 is a member of the MMP family and is upregulated in the epithelial cells of gastric cancer; it can promote cancer invasion by the proteolytic cleavage of extracellular matrix substrates [11] [12] [13] . Previous studies have reported that virulent H. pylori strains resulted in the selective induction of MMP-7 in vitro and in the gastric mucosa [14, 15] . The goal of the present study was to identify virulent H. pylori strains and the expression of MMP-7 in samples of gastric epithelial dysplasia and intramucosal cancer, obtained by endoscopic mucosal resection, in order to elucidate the effects of virulent H. pylori strains during the early stages of malignant transformation.
Methods

Ethical statement
Human samples were used according to the guidelines of the Ethics Committee of the Catholic University of Korea.
Materials
All tissues were therapeutically excised by endoscopic mucosal resection. The diagnosis of the tissue samples, according to the revised Vienna classifi cation [16] , was confi rmed by two different histopathologists; when the reviewers disagreed, the tissue sample was excluded from the study. We did not include samples with noninvasive carcinoma in situ [CIS], category 4.2) or samples suspicious of invasive carcinoma (category 4.3). A total of 149 tissue samples were analyzed; 37 tissue samples were excluded because of disagreement on the diagnosis or because of inappropriate tissue preparation. The remaining 112 samples had gastric epithelial dysplasia and intramucosal cancer and were included in the analysis.
Seventy-six samples with gastric dysplasia and 36 intramucosal cancer tissue samples were paired with adjacent normal mucosal tissues. All normal tissues had grossly intact mucosa and were at least 1 cm from the mucosal lesion; they were taken as a gastric biopsy just after the endoscopic mucosal resection. Microscopic examination showed no evidence of malignant cells. Grading of gastritis (infi ltration by chronic infl ammatory cells and polymorphonuclear neutrophil [PMN] cells) was performed using the updated Sydney system [17] , a scoring system with scores ranging from 0 = none to 3 = severe. The presence of intestinal metaplasia was also observed. Morphometric changes of gastric mucosal atrophy (closed or open type) were decided by endoscopic fi ndings. The baseline characteristics of this study population and differences between the groups are summarized in Table 1 .
H. pylori status
Each patient was classifi ed as H. pylori-positive or -negative according to the histological results. In the present study, the resection specimen and gastric biopsy of surrounding mucosa were stained with hematoxylin and eosin and silver stains. To assess H. pylori status accurately, two biopsies were taken, from both antrum and corpus, 4 weeks after the endoscopic resection. We evaluated H. pylori status with the CLO test or by histological examination. Grading of gastritis (infi ltration by chronic infl ammatory cells and polymorphonuclear neutrophil (PMN) cells) was performed using the updated Sydney system
DNA extraction
Two 10-μm-thick tissue sections, from cancer samples and normal tissues, were placed on glass slides. Then xylene (1 ml) was added to the tissue sections, and they were incubated for 10 min; this process was repeated three times. The slides were then dehydrated in graded ethanol solution (100% ethanol; 1 ml) and dried without a cover glass for 10 min; this procedure was repeated three times. The DNA was extracted from the tissues with 20 μl of extraction buffer (100 mmol/l Tris-HCl; 2 mmol/l ethylenediamine tetraacetic acid [EDTA], pH 8.0; 400 μg/ml of proteinase K) at 55 °C overnight. The tubes were boiled for 7 min to inactivate the proteinase K, and were cooled on ice. Then 20 μl phenol : chloroform : isoamyl alcohol (25 : 24 : 1) solution was added and the tubes were centrifuged at 12 000 rpm, at 4 °C for 5 min. This was a de-proteinization process to extract DNA from the tissue. Ethanol (1 ml; 100%) was added to the supernatant by and the tube was gently inverted.
It was incubated at −20 °C for 10 min and centrifuged at 12 000 rpm, 4 °C for 5 min. A DNA pellet was made by washing with ethanol (1 ml, 75%) and centrifuging at 14 000 rpm for 5 min. The pellet was dissolved by the addition of 20 μl dextrose water, and then 1 μl of this extract was used for each polymerase chain reaction (PCR) amplifi cation.
PCR for cagA and cagL associated with H. pylori PCR analysis for cag PAI was performed to amplify the cagA and cagL genes. The primers used for detecting the H. pylori-specifi c cagA and cagL region were 5′-GAT AAC AGG CAA GCT TTT GA-3′ (F)/ 5′-CCG AAC GGA TCA AAA ATT CAT GG-3′ (R)(GenBank accession number, AF001357) and 5′-TAT TGT CTG TTT TGA TGG CAG AAG-3′ (F)/ 5′-CGG ATA TTC CGC ATT GTT GC-3′(R). The PCR reaction was set up using i-star Taq DNA polymerase (iNtRON, Seongnam, Korea). The PCR amplifi cation protocol was as follows: 95 °C for 5 min, then denaturing at 94 °C for 30 s, annealing at 50 °C for 30 s, extension at 72 °C for 1 min for 35 cycles, and then a fi nal extension at 72 °C for 10 min. The amplifi ed products were electrophoresed on 2% agarose gels, and then visualized with ethidium bromide (Fig. 1) .
Immunohistochemical staining of matrix metalloproteinase-7
Four-micrometer-thick tissue sections from the dysplasia/cancer specimens were placed on a glass slide and stained with antibodies to MMP-7 (Abcam, Cambridge, UK). The samples were deparaffi nized in xylene and rehydrated in graded ethanol. Endogenous peroxidase activity was blocked with 3% H 2 O 2 in phosphatebuffered saline. For antigen retrieval, the sections were incubated in 10 mM of citrate buffer (pH 6.0), using a microwave oven. Then the sections were incubated for 30 min at room temperature with anti-MMP-7 antibodies (5 μg/ml). Antibody detection was performed using the IMPRESS peroxidase reagent kit (Vector Laboratories, Burlingame, CA, USA) according to the manufacturer's protocol. MMP-7-positive cells were identifi ed using a DAB peroxidase substrate kit (Vector Laboratories,).
We assessed the MMP-7 staining intensity. We were particularly interested in the localization of the immunoreactivity. The stained samples were divided into two categories: a dispersed cytoplasm pattern and nucleus/ subnucleus condensation, and the staining intensity was graded from 0 (no staining) to 3 (intense staining) (Fig. 2) . If both cytoplasm and nucleus/subnucleus condensation were observed, the total score for MMP-7 expression was the staining intensity plus one point (Fig.   Fig. 1 . Representative example of polymerase chain reaction (PCR) for cagA and cagL associated with Helicobacter pylori. N, Normal tissue; T, tumor 3). The observers were blinded to the H. pylori status and the tissue diagnosis.
Statistical analysis
For quantitative variables, the mean and SD were calculated. For qualitative variables, the percentages and their 95% confi dence intervals (95% CIs) were calculated. We used the χ 2 test to analyze the association between the H. pylori status and the prevalence of cagA/cagL. For comparisons of age and grade of MMP-7 expression, we used the unpaired t-test and one-way analysis of variance (ANOVA). The SPSS statistical package software for Windows release 12.0 (SPSS, Chicago, IL, USA) was used for all analyses. Significance was defi ned as P < 0.05.
Results
A total of 149 tissue samples were analyzed; 37 tissue samples were excluded. The concordance rate between the two histopathologists was 75.2%. Samples from 112 patients with gastric epithelial dysplasia and intramucosal cancer were available for the analysis. The H. pylori status was evaluated according to the histological results (silver stain or CLO test); there were 37 cases (37/76; 48.7%) of gastric dysplasia and 25 (25/36; 69.4%) of intramucosal cancer that were associated with H. pylori infection. There were signifi cant differences in H. pylori infection and cag PAI-positive rates between the gastric epithelial dysplasia specimens and the intramucosal cancers (Table 2) .
When all sample tissues were categorized according to the revised Vienna classifi cation (46 patients with low-grade dysplasia, 30 with high-grade dysplasia, and 36 with intramucosal gastric cancer), the positive rate for cagA was 52.4% (11/21) in category 3 cases (lowgrade dysplasia). For categories 4.1 (high-grade dysplasia) and 4.4 (intramucosal carcinoma), the rates were 60% (9/15) and 88.0% (22/25) respectively. There was an increasing tendency for intramucosal cancers to have a higher rate of positive cagA results compared to the other samples (P = 0.02).
We assessed the intensity and localization of MMP-7 immunoreactivity. There was a signifi cant difference in the grade of intensity between the gastric epithelial dysplasias and the intramucosal cancers (2.18 ± 0.76, 2.58 ± 0.77; P = 0.01). When the lesions were categorized by the revised Vienna classifi cation subgroups, the intensity of MMP-7 immunoreactivity had an increasing tendency from category 3 to category 4.4 (2.15 ± 0.63, 2.23 ± 0.58, 2.58 ± 0.77, P = 0.03; Fig. 4) . As for the nucleus/ subnucleus condensation of MMP-7 immunoreactivity, this was less frequent in gastric dysplasia samples than in the intramucosal cancers (15.8%; 12/76 vs 33.3%; 12/36; P = 0.03).
When we compared H. pylori-positive gastric dysplasia with H. pylori-negative gastric dysplasia, MMP-7 immunoreactivity was more intense in the H. pyloripositive samples, but the difference was not signifi cant (2.19 ± 0.77 vs 2.08 ± 0.70; P = 0.51). In the intramucosal cancers, H. pylori-positive lesions showed more intense 
Discussion
Epidemiologically, H. pylori is now recognized as the major cause of gastric cancer [18, 19] . In a subgroup with gastric atrophy and intestinal metaplasia, the eradication of H. pylori has been associated with the prevention or regression of these lesions, and the induction of apoptosis; in addition, H. pylori eradication has been shown to inhibit proliferation in H. pylori-infected gastric mucosa in animal models [20] [21] [22] [23] . However, the effect of H. pylori eradication on premalignant lesions such as dysplasia and intramucosal cancer has not been determined. The effect of H. pylori treatment on the prevention of gastric cancer development remains controversial [24, 25] . In the present study, we investigated the pathogenic role of virulent strains of H. pylori during the early stage of gastric carcinogenesis. The results showed that the frequency of cagA-positive H. pylori was greater in intramucosal cancers than in gastric epithelial dysplasias, although a selection bias of sample tissues could not be completely ruled out. Gastric infl ammation, atrophy, and intestinal metaplasia are already considered risk factors for gastric carcinogenesis [26] . Herein we showed that acute infl ammation around intramucosal cancer was more intense than that around gastric dysplasia. The association between chronic infl ammation and cancer is now well established, and H. pylori could be responsible for the chronic infl ammation observed in gastric cancer [27] . We thought that bacterial virulence factors were more prevalent in intramucosal cancer than in gastric dysplasia and that they contributed to the more intense infi ltration of PMN cells; this infi ltration could play a role in the breakdown of the local epithelial barrier and the ongoing infl ammation that progresses to gastric cancer. However, the results showing PMN infi ltration had a great limitation, as there was no control group and no control biopsy specimens.
When all the sample tissues in the present study were subgrouped according to the revised Vienna classifi cation, the frequency of cagA-positive H. pylori was shown to be signifi cantly greater in cases with high-grade dysplasia (category 4.1) and intramucosal cancer (category 4.4) than in the other categories, illustrating disease progression. We did not include samples with noninvasive carcinoma (category 4.2) or samples suspicious of invasive carcinoma (category 4.3), because the use of these terms could be confusing in diagnosis according to whether a pathologist uses Western or Japanese nomenclature. In the West, noninvasive high-grade neoplasia is usually regarded as dysplasia that has not yet achieved invasion. In Japan, the same term means carcinoma in situ or superfi cial carcinoma that has already acquired the potential to invade, even if the potential is not currently realized. To make our results clear, we chose the defi nite terms "dysplasia" and "intramucosal carcinoma" for the lesions when two pathologists agreed on the diagnosis.
Although in the past many attempts have been made to understand and fi nd a causal link between virulent H. pylori infection and specifi c gastrointestinal disease, data have been confl icting due to differences in study populations and designs. Especially in East Asia, several reports have not confi rmed an association between cagA and disease, suggesting that the cagA gene is not a suitable marker for cag PAI-associated virulence [28] [29] [30] . In another report, the presence of an intact cag PAI was correlated with the development of more severe pathology, and a partial deletion of cag appeared to render the organism less pathogenic [31] . These fi ndings suggest that the presence of the cagA gene does not always signify that the presence of an intact cag PAI or other distinct cagA gene fragment -close to the pro- moter region or the cagA gene itself -is particularly associated with gastric pathology. In the present study, we selected primers for the cagA gene that were very close to the promoter region and were previously described by Ikenoue [32] , who reported that the promoter region of the cagA gene, not the cagA gene itself, might be a better marker for cag PAI-associated virulence. Also, we detected the cagL gene in neoplasia and paired normal specimens and we attempted to examine the pure intact state of cag PAI.
The extracellular matrix provides a structural framework for the support of cells and helps maintain cellular function. Cellular growth, migration, and degradation are dependent on the remodeling of the extracellular matrix, which is controlled by proteolytic enzymes called matrix metalloproteinases (MMPs) [33] [34] [35] . Especially, MMP-7, or matrilysin, is a secreted protease expressed by glandular and mucosal epithelial cells, keratinocytes, fi broblasts, and macrophages. It is expressed by tumor cells themselves and can be characterized in a tumorassociated fashion. At the gene level, nuclear β-catenin enhances the expression of the MMP-7 gene by binding with the T-cell factor/lymphoid enhancer factor family of transcription factors [36, 37] . As a consequence, this enzyme plays a signifi cant role in the development of tumors. In previous reports, MMP-7 was upregulated in H. pylori gastritis, and this was the fi rst stage in the progression to gastric carcinoma [14, 15] . Elevated levels of MMP-7 have been detected in malignant lesions of the stomach [13, [37] [38] [39] [40] [41] . In both in vitro studies and in healthy subjects, the increased expression of MMP-7 induced in an H. pylori cag PAI-dependent manner was suggested to contribute to gastric carcinogenesis [14, 42] . The goal of the present study was to determine whether cag status might alter the expression of MMP-7 in premalignant or early cancerous lesions.
We examined the expression of MMP-7 immunohistochemically and focused on the intensity and localization of MMP-7 in gastric epithelial dysplasia and intramucosal cancer samples, to determine the presence of cag PAI. Our results showed that intramucosal cancer had more intense MMP-7 immunoreactivity than gastric epithelial dysplasia. When we evaluated the relationship of H. pylori status and MMP immunoreactivity, a stronger response to MMP was noted in H. pylori-positive intramucosal cancer than in H. pylori-negative intramucosal cancer. Moreover, when the lesions infected with virulent H. pylori strains were compared with the lesions not infected with these strains, the intramucosal cancers had a more intense response. As these results suggest, H. pylori-associated or cag PAI-dependent MMP-7 upregulation could play an important role in the early changes in gastric carcinogenesis.
The expression of MMP-7 induced by virulent H. pylori strains has been identifi ed in surface epithelial cells where there was dispersed staining of the cytoplasm that tended to be subnuclear on the basolateral side of the cells [43] . Our results revealed that the nuclear/subnuclear condensation of MMP-7 immunoreactivity in the intramucosal cancers was greater than that in the gastric dysplasia samples. Just prior to the invasive stage of epithelial tumors, basolateral staining (nuclear/subnuclear condensation) of MMP-7 has been observed, suggesting a direct role of MMP-7 as a matrixdegrading protease. This may be correlated with the activity of MMP-7 when it is released at either the apical or basolateral compartment. MMP-7 acts on various bioactive substrates -tumor necrosis factor-α, Fas ligand, heparin-binding epidermal growth factor, Ecadherin, and β4-integrin; in addition, the expression of MMP-7 is upregulated with tumor formation and progression [44] [45] [46] .
In conclusion, infection with a virulent H. pylori strain is associated with early-stage gastric carcinogenesis that is associated with cag PAI-dependent MMP-7 upregulation. Large prospective studies are needed to further analyze the risk factors for gastric carcinogenesis and to clarify whether H. pylori eradication therapy is capable of preventing gastric carcinoma.
